US Patent 7556795 Radiopharmaceutical formulations
Patent 7556795 was granted and assigned to Bracco (company) on July, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Aldo Cagnolini0
Jianqing Chen0
Karen E. Linder0
Nannan Wang0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+310 characters)
Article
Patent abstract
Radiopharmaceutical compounds are disclosed having a radionuclide chelating moiety and a targeting ligand, and optionally a linker. Formulations of compositions useful for making the radiopharmaceutical compounds contain a chelating ligand, a reducing agent, an exchange ligand and a stabilizer.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07556795 Radiopharmaceutical formulations US Patent 7556795 Radiopharmaceutical formulations
Infobox
Patent Number
07556795
Patent Number
7556795
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07556795 Radiopharmaceutical formulations
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07556795
Date of patent
July 7, 2009
Patent application number
10513586
Date Filed
May 5, 2003
Patent primary examiner
Find more entities like US Patent 7556795 Radiopharmaceutical formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
